Addressing Challenges to Access, Advancement of Myeloma Therapies

Estimated read time 1 min read

In an interview with Pharm Exec Associate Editor Don Tracy, Joseph Mikhael, MD, chief medical officer, IMF, discusses challenges of access and advancement of myeloma therapies.

You May Also Like

More From Author

+ There are no comments

Add yours